Azalanstat

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAzalanstat
Drug Alias Name阿扎兰司他azalanstatumRS-21607RS-21607-197RS-21607-007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 51 inhibitors
TargetsCytochrome P450 51
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsHyperlipidemias

Other Information

ATC CodeN/A
Related LinksKEGG